Literature DB >> 15831455

FAT10, a ubiquitin-independent signal for proteasomal degradation.

Mark Steffen Hipp1, Birte Kalveram, Shahri Raasi, Marcus Groettrup, Gunter Schmidtke.   

Abstract

FAT10 is a small ubiquitin-like modifier that is encoded in the major histocompatibility complex and is synergistically inducible by tumor necrosis factor alpha and gamma interferon. It is composed of two ubiquitin-like domains and possesses a free C-terminal diglycine motif that is required for the formation of FAT10 conjugates. Here we show that unconjugated FAT10 and a FAT10 conjugate were rapidly degraded by the proteasome at a similar rate. Fusion of FAT10 to the N terminus of very long-lived proteins enhanced their degradation rate as potently as fusion with ubiquitin did. FAT10-green fluorescent protein fusion proteins were not cleaved but entirely degraded, suggesting that FAT10-specific deconjugating enzymes were not present in the analyzed cell lines. Interestingly, the prevention of ubiquitylation of FAT10 by mutation of all lysines or by expression in ubiquitylation-deficient cells did not affect FAT10 degradation. Thus, conjugation with FAT10 is an alternative and ubiquitin-independent targeting mechanism for degradation by the proteasome, which, in contrast to polyubiquitylation, is cytokine inducible and irreversible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15831455      PMCID: PMC1084302          DOI: 10.1128/MCB.25.9.3483-3491.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  39 in total

1.  The ubiquitin-related BAG-1 provides a link between the molecular chaperones Hsc70/Hsp70 and the proteasome.

Authors:  J Lüders; J Demand; J Höhfeld
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

Review 2.  Ubiquitin and its kin: how close are the family ties?

Authors:  S Jentsch; G Pyrowolakis
Journal:  Trends Cell Biol       Date:  2000-08       Impact factor: 20.808

Review 3.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 4.  Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome.

Authors:  K D Wilkinson
Journal:  Semin Cell Dev Biol       Date:  2000-06       Impact factor: 7.727

5.  Detecting and measuring cotranslational protein degradation in vivo.

Authors:  G C Turner; A Varshavsky
Journal:  Science       Date:  2000-09-22       Impact factor: 47.728

6.  Rad23 links DNA repair to the ubiquitin/proteasome pathway.

Authors:  C Schauber; L Chen; P Tongaonkar; I Vega; D Lambertson; W Potts; K Madura
Journal:  Nature       Date:  1998-02-12       Impact factor: 49.962

7.  NUB1, a NEDD8-interacting protein, is induced by interferon and down-regulates the NEDD8 expression.

Authors:  K Kito; E T Yeh; T Kamitani
Journal:  J Biol Chem       Date:  2001-03-19       Impact factor: 5.157

8.  Proteasomal turnover of p21Cip1 does not require p21Cip1 ubiquitination.

Authors:  R J Sheaff; J D Singer; J Swanger; M Smitherman; J M Roberts; B E Clurman
Journal:  Mol Cell       Date:  2000-02       Impact factor: 17.970

9.  A ubiquitin-like protein which is synergistically inducible by interferon-gamma and tumor necrosis factor-alpha.

Authors:  S Raasi; G Schmidtke; R de Giuli; M Groettrup
Journal:  Eur J Immunol       Date:  1999-12       Impact factor: 5.532

10.  The ubiquitin-like protein FAT10 forms covalent conjugates and induces apoptosis.

Authors:  S Raasi; G Schmidtke; M Groettrup
Journal:  J Biol Chem       Date:  2001-07-09       Impact factor: 5.157

View more
  74 in total

1.  Increased expression of FAT10 is correlated with progression and prognosis of human glioma.

Authors:  Jun Yuan; Yanyang Tu; Xinggang Mao; Shiming He; Liang Wang; Guoqiang Fu; Jianhai Zong; Yongsheng Zhang
Journal:  Pathol Oncol Res       Date:  2012-03-09       Impact factor: 3.201

2.  USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.

Authors:  Annette Aichem; Christiane Pelzer; Sebastian Lukasiak; Birte Kalveram; Paul W Sheppard; Neha Rani; Gunter Schmidtke; Marcus Groettrup
Journal:  Nat Commun       Date:  2010-05-04       Impact factor: 14.919

Review 3.  Cardiac function and disease: emerging role of small ubiquitin-related modifier.

Authors:  Jun Wang
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2010-12-31

Review 4.  Post-translational modification and protein sorting to small extracellular vesicles including exosomes by ubiquitin and UBLs.

Authors:  Hiroshi Ageta; Kunihiro Tsuchida
Journal:  Cell Mol Life Sci       Date:  2019-07-30       Impact factor: 9.261

5.  FAT10 protein binds to polyglutamine proteins and modulates their solubility.

Authors:  Yu Nagashima; Hisatomo Kowa; Shoji Tsuji; Atsushi Iwata
Journal:  J Biol Chem       Date:  2011-07-08       Impact factor: 5.157

6.  FAT10 protects cardiac myocytes against apoptosis.

Authors:  Xiaogang Peng; Jianghua Shao; Yang Shen; Yunguo Zhou; Qing Cao; Jinzhu Hu; Wenfeng He; Xin Yu; Xiuxia Liu; Ali J Marian; Kui Hong
Journal:  J Mol Cell Cardiol       Date:  2013-02-13       Impact factor: 5.000

7.  Profiling of ubiquitin-like modifications reveals features of mitotic control.

Authors:  Yifat Merbl; Phillipe Refour; Hevan Patel; Michael Springer; Marc W Kirschner
Journal:  Cell       Date:  2013-02-28       Impact factor: 41.582

8.  The ubiquitin-like protein FAT10 mediates NF-kappaB activation.

Authors:  Pengfei Gong; Allon Canaan; Bin Wang; Jeremy Leventhal; Alexandra Snyder; Viji Nair; Clemens D Cohen; Matthias Kretzler; Vivette D'Agati; Sherman Weissman; Michael J Ross
Journal:  J Am Soc Nephrol       Date:  2009-12-03       Impact factor: 10.121

9.  Integrative Genomics Identifies Novel Associations with APOL1 Risk Genotypes in Black NEPTUNE Subjects.

Authors:  Matthew G Sampson; Catherine C Robertson; Sebastian Martini; Laura H Mariani; Kevin V Lemley; Christopher E Gillies; Edgar A Otto; Jeffrey B Kopp; Anne Randolph; Virginia Vega-Warner; Felix Eichinger; Viji Nair; Debbie S Gipson; Daniel C Cattran; Duncan B Johnstone; John F O'Toole; Serena M Bagnasco; Peter X Song; Laura Barisoni; Jonathan P Troost; Matthias Kretzler; John R Sedor
Journal:  J Am Soc Nephrol       Date:  2015-07-06       Impact factor: 10.121

10.  Transcriptional profiling of the effects of 25-hydroxycholesterol on human hepatocyte metabolism and the antiviral state it conveys against the hepatitis C virus.

Authors:  John Paul Pezacki; Selena M Sagan; Angela M Tonary; Yanouchka Rouleau; Sylvie Bélanger; Lubica Supekova; Andrew I Su
Journal:  BMC Chem Biol       Date:  2009-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.